This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrei, G.
Right arrow Articles by Evans, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrei, G.
Right arrow Articles by Evans, D. H.

 Previous Article  |  Next Article 

Journal of Virology, October 2006, p. 9391-9401, Vol. 80, No. 19
0022-538X/06/$08.00+0     doi:10.1128/JVI.00605-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Cidofovir Resistance in Vaccinia Virus Is Linked to Diminished Virulence in Mice

Graciela Andrei,1,§ Don B. Gammon,2,§ Pierre Fiten,3 Erik De Clercq,1 Ghislain Opdenakker,3 Robert Snoeck,1 and David H. Evans2*

Laboratory of Virology,1 Laboratory of Immunobiology, Rega Institute for Medical Research, Minderbroedersstraat 10, Katholieke Universiteit Leuven, Leuven B-3000, Belgium,3 Department of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton AB T6G 2H7, Canada2

Received 24 March 2006/ Accepted 14 July 2006

Cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC)] is recognized as a promising drug for the treatment of poxvirus infections, but drug resistance can arise by a mechanism that is poorly understood. We show here that in vitro selection for high levels of resistance to HPMPC produces viruses encoding two substitution mutations in the virus DNA polymerase (E9L) gene. These mutations are located within the regions of the gene encoding the 3'-5' exonuclease (A314T) and polymerase (A684V) catalytic domains. These mutant viruses exhibited cross-resistance to other nucleoside phosphonate drugs, while they remained sensitive to other unrelated DNA polymerase inhibitors. Marker rescue experiments were used to transfer A314T and/or A684V alleles into a vaccinia virus Western Reserve strain. Either mutation alone could confer a drug resistance phenotype, although the degree of resistance was significantly lower than when virus encoded both mutations. The A684V substitution, but not the A314T change, also conferred a spontaneous mutator phenotype. All of the HPMPC-resistant recombinant viruses exhibited reduced virulence in mice, demonstrating that these E9L mutations are inextricably linked to reduced fitness in vivo. HPMPC, at a dose of 50 mg/kg of body weight/day for 5 days, still protected mice against intranasal challenge with the drug-resistant virus with A314T and A684V mutations. Our studies show that proposed drug therapies offer a reasonable likelihood of controlling orthopoxvirus infections, even if the viruses encode drug resistance markers.

* Corresponding author. Mailing address: Department of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton AB T6G 2H7, Canada. Phone: (780) 492-2308. Fax: (780) 492-7521. E-mail: devans{at}ualberta.ca.

§ G. Andrei and D. B. Gammon contributed equally to this work.

Journal of Virology, October 2006, p. 9391-9401, Vol. 80, No. 19
0022-538X/06/$08.00+0     doi:10.1128/JVI.00605-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Vigne, S., Duraffour, S., Andrei, G., Snoeck, R., Garin, D., Crance, J.-M. (2009). Inhibition of Vaccinia Virus Replication by Two Small Interfering RNAs Targeting B1R and G7L Genes and Their Synergistic Combination with Cidofovir. Antimicrob. Agents Chemother. 53: 2579-2588 [Abstract] [Full Text]  
  • Gammon, D. B., Evans, D. H. (2009). The 3'-to-5' Exonuclease Activity of Vaccinia Virus DNA Polymerase Is Essential and Plays a Role in Promoting Virus Genetic Recombination. J. Virol. 83: 4236-4250 [Abstract] [Full Text]  
  • Teale, A., Campbell, S., Van Buuren, N., Magee, W. C., Watmough, K., Couturier, B., Shipclark, R., Barry, M. (2009). Orthopoxviruses Require a Functional Ubiquitin-Proteasome System for Productive Replication. J. Virol. 83: 2099-2108 [Abstract] [Full Text]  
  • Gammon, D. B., Snoeck, R., Fiten, P., Krecmerova, M., Holy, A., De Clercq, E., Opdenakker, G., Evans, D. H., Andrei, G. (2008). Mechanism of Antiviral Drug Resistance of Vaccinia Virus: Identification of Residues in the Viral DNA Polymerase Conferring Differential Resistance to Antipoxvirus Drugs. J. Virol. 82: 12520-12534 [Abstract] [Full Text]  
  • Magee, W. C., Aldern, K. A., Hostetler, K. Y., Evans, D. H. (2008). Cidofovir and (S)-9-[3-Hydroxy-(2-Phosphonomethoxy)Propyl]Adenine Are Highly Effective Inhibitors of Vaccinia Virus DNA Polymerase When Incorporated into the Template Strand. Antimicrob. Agents Chemother. 52: 586-597 [Abstract] [Full Text]  
  • Quenelle, D. C., Prichard, M. N., Keith, K. A., Hruby, D. E., Jordan, R., Painter, G. R., Robertson, A., Kern, E. R. (2007). Synergistic Efficacy of the Combination of ST-246 with CMX001 against Orthopoxviruses. Antimicrob. Agents Chemother. 51: 4118-4124 [Abstract] [Full Text]  
  • Hamilton, M. D., Nuara, A. A., Gammon, D. B., Buller, R. M., Evans, D. H. (2007). Duplex strand joining reactions catalyzed by vaccinia virus DNA polymerase. Nucleic Acids Res 35: 143-151 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»